Furthermore, a significant correlation was observed between TPM1 peptide 846 and baseline NIHSS scores (r ~ 0.8, Figure 3E), indicating that higher levels of TPM1 are associated with worse clinical status in cardioembolic patients at the onset of stroke. This evidence concerns the gene TPM1 and stroke disorder.